Cancer-Associated Fibroblasts in Pancreatic Ductal Adenocarcinoma and Determine the Response to SLC7A11 Inhibition

Name: Cancer-Associated Fibroblasts in Pancreatic Ductal Adenocarcinoma and Determine the Response to SLC7A11 Inhibition
Start: 2023-11-25T16:00:00+00:00
End: 2023-11-25T17:00:00+00:00

25th Nov 2023

4:00 - 5:00pm (GMT)

Clinical oncology

Clinical pharmacology and therapeutics

Gynaecological oncology

25th Nov 2023

4:00 - 5:00pm (GMT)

Hosted on MedAll

Attendance certificate available

This event has ended. Similar events

Free

ONLINE

Description

Plunge into an illuminating exploration of cutting-edge medical research s Join us at the GIMSOC Monthly Medical Journal Meeting on November 25th at 8 p.m. as we unravel the complexities of 'Cancer-Associated Fibroblasts in Pancreatic Ductal Adenocarcinoma and Determine the Response to SLC7A11 Inhibition. This insightful event takes place virtually via the MedAll platform, uniting minds to delve into groundbreaking insights in the battle against pancreatic cancer. * O. Don't miss this chance to contribute to shaping the future of healthcare

Learning objectives

1. Recognize the characteristics of cancer-associated fibroblasts in pancreatic ductal adenocarcinoma. 2. Explain how to effectively measure the mechanisms of SLC7A11 inhibition. 3. Compare the effects of SLC7A11 inhibition in pancreatic ductal adenocarcinoma. 4. Utilize the MedAll platform to access and share insights into pancreatic cancer treatment. 5. Apply newly acquired knowledge to raise awareness and improve patient care.

Generated by MedBot

Speaking at this event

View all